Thank you.
Further to that, and I'll be the first to agree, we see plenty of very cheap, effective medications and we see very expensive ones with questionable benefit at best.
Steven Morgan spoke to us in an earlier meeting. He suggested starting with a limited formulary and then evaluating that and stepping forward in an incremental approach. Others might advocate putting together a master formulary and starting with a more robust system.
If you had to pick between a completed system that you put in or putting it in incrementally, which would be the model you'd recommend?